News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Why M&A Hungry Sanofi Could be Gearing Up to Buy Sarepta
May 1, 2017
·
2 min read
Genetown
Here’s Why Sarepta May Be The Rarest Of Finds: A ‘Value’ Biotech Stock
May 1, 2017
·
1 min read
Business
M&A Speculation Begins as Sarepta CEO Puts in His Notice
April 28, 2017
·
2 min read
Business
Sarepta CEO Gives CMO Role to Former Amgen-Regeneron Alum
April 4, 2017
·
3 min read
Deals
Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million
February 21, 2017
·
2 min read
FDA
Sarepta Under Pressure As Marathon Pharma Emflaza’s Wins FDA Approval for DMD
February 10, 2017
·
3 min read
Genetown
JPM17: Sarepta’s New Numbers Impress Investors, Stock Gained $300 Million Overnight
January 11, 2017
·
2 min read
Deals
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro and Sarepta
November 11, 2016
·
3 min read
Job Trends
Sarepta’s New Facility to Open in Early 2017, Plans to Hire 45 New Staffers
November 4, 2016
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments on March 1, 2021
February 22, 2021
·
1 min read
Business
Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition
February 4, 2021
·
3 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 30, 2021
January 29, 2021
·
2 min read
Business
Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics
January 13, 2021
·
7 min read
Genetown
Sarepta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 8, 2021
·
1 min read
Drug Development
Sarepta Therapeutics Announces Top-line Results for Part 1 of Study 102 Evaluating SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
January 7, 2021
·
12 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec 31, 2020
December 31, 2020
·
2 min read
Business
Sarepta Therapeutics Announces Executive Management Changes
December 14, 2020
·
9 min read
Drug Development
Sarepta Therapeutics Announces Positive Clinical Results from MOMENTUM, a Phase 2 Clinical Trial of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51
December 7, 2020
·
10 min read
Genetown
Sarepta Therapeutics to Share Clinical Update for SRP-5051, its Investigational PPMO for the Treatment of Duchenne Muscular Dystrophy
December 4, 2020
·
2 min read
